FENG, JIANWEN,LOKE, PUI LENG,MONTALBETTI, CHRISTIAN A.G.N.,STABEN, STEVEN
申请号:
CA2827161
公开号:
CA2827161A1
申请日:
2012.03.15
申请国别(地区):
CA
年份:
2012
代理人:
摘要:
The invention relates to novel compounds of Formula (I) wherein A, Y, R1, R2 and the subscript b each has the meaning as described herein and compounds of Formula I, and stereoisomers, geometric isomers, tautomers, solvates, metabolites, isotopes, pharmaceutically acceptable salts, or prodrugs thereof. Compounds of Formula I and pharmaceutical compositions thereof are useful in the treatment of disease and disorders in which undesired or over-activation of NF-kB signaling is observed.